Assertio Holdings, Inc. ASRT
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 1997-02-12
Assertio Holdings, Inc. statistics & valuation
Market cap as of 2026-07-01. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Operating margin | -18.1% | -19.6% | -160.1% | 25.2% | 8.5% | -77.3% | -84.7% |
| Net margin | -25.6% | -17.3% | -218.3% | 70.2% | -1.2% | -26.5% | -94.6% |
| FCF margin | — | 21.1% | 32.2% | 50.1% | 4.9% | -61.7% | 38.8% |
| Return on assets | -11.4% | -7.6% | -115.9% | 26.5% | -0.4% | -9.3% | -41.2% |
| Return on equity | -32.3% | -17.8% | -240.5% | 48.6% | -1.3% | -50.7% | -374.8% |
| Debt / equity | 0.42× | 0.32× | 0.28× | 0.30× | 0.72× | 1.51× | 6.06× |
| Current ratio | 1.70 | 1.77 | 1.83 | 1.39 | 0.77 | 0.71 | 0.56 |
Source: SEC EDGAR filings · CIK 0001808665 · US · as of 2025-12-31. facts plus Stocktoria's own computed scores — not investment advice.